Skip to main content

Table 2 Patients' summary score distribution (treatment response distribution) according to the biomarker pattern observed during the treatment time-course.

From: Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis

Pattern

MR

SD

P

MDT

Continuously decline

11

2

3

1

Rise and fall

2

6

6

3

  1. MR: Measurable Response; SD: Stable Disease; P: Progression; MDT: Mortality during treatment
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us